Showing 1 - 10 results of 10 for search 'Luntz S', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS - a... by Rahbari Nuh N, Lordick Florian, Fink Christine, Bork Ulrich, Stange Annika, Jäger Dirk, Luntz Steffen P, Englert Stefan, Rossion Inga, Koch Moritz, Büchler Markus W, Kieser Meinhard, Weitz Jürgen
Published 2012-04-01
Article -
7
A NOMENCLATURE FOR LAMBDA-DOUBLET LEVELS IN ROTATING LINEAR-MOLECULES by Alexander, M, Andresen, P, Bacis, R, Bersohn, R, Comes, F, Dagdigian, P, Dixon, R, Field, R, Flynn, G, Gericke, K, Grant, E, Howard, B, Huber, J, King, D, Kinsey, J, Kleinermanns, K, Kuchitsu, K, Luntz, A, Mccaffery, A, Pouilly, B, Reisler, H, Rosenwaks, S, Rothe, E, Shapiro, M, Simons, J
Published 1988Journal article -
8
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial by Hans Salwender, Niels Weinhold, Axel Benner, Kaya Miah, Maximilian Merz, Mathias Haenel, Christian Jehn, Elias Mai, Ekaterina Menis, Igor Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Steffen Luntz, Britta Besemer, Markus Munder, Peter Brossart, Bertram Glass, Hans-Walter Lindemann, Katja Weisel, Christine Hanoun, Paul Schnitzler, Sarah Klemm, Hartmut Goldschmidt, Marc Raab, Ahmet Elmaagacli
Published 2024-12-01
Article -
9
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial by Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Marc S. Raab, Igor W. Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, on behalf of the German-Speaking Myeloma Multicenter Group (GMMG)
Published 2021-09-01
Article -
10
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO... by E. K. Mai, U. Bertsch, R. Fenk, D. Tichy, B. Besemer, J. Dürig, R. Schroers, I. von Metzler, M. Hänel, C. Mann, A. M. Asemissen, B. Heilmeier, E. Nievergall, S. Huhn, K. Kriegsmann, N. Weinhold, S. Luntz, T. A. W. Holderrried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, C. Khandanpour, W. Knauf, C. Scheid, M. Munder, T. Geer, H. Riesenberg, J. Thomalla, M. Hoffmann, M. S. Raab, H. J. Salwender, K. C. Weisel, H. Goldschmidt
Published 2022-06-01
Article